The first implants of the Israeli startup CorNeat Vision’s synthetic cornea, which bio-integrates with the host’s eye, has received approval to conduct clinical trials on patients at Beilinson Hospital in central Israel.
By ILH Staff
The Israeli startup CorNeat Vision has received approval to conduct clinical trials of a synthetic cornea that bio-integrates with the human eye.
The Health Ministry-approved trial of the CorNeat KPro will be run at Beilinson Hospital in Petach Tikva on 10 patients suffering from corneal blindness who are either not candidates for or have experienced one or more failed cornea transplants, the company announced last week. Continue Reading »
The new MRI technique developed by Hebrew University of Jerusalem researchers is especially important for understanding whether a patient is merely getting older or is developing a disease such as Parkinson’s or Alzheimer’s.
By Naama Barak
MRI, or magnetic resonance imaging, already does pretty amazing work giving us a better picture of what’s happening on our insides. But it is about to do even more amazing work, helping doctors determine more quickly the onset of neurodegenerative diseases.
A team of researchers from the Hebrew University of Jerusalem, led by Dr. Aviv Mezer, found a way for MRIs to record changes in the biological makeup of brain tissue. Continue Reading »
Researchers at Israel’s Institute of Technology, the Haifa based Technion, are developing complex & precise artificial cells, tissues and organs to aid treatment in all areas of regenerative medicine.
By Naama Barak
The Technion-Israel Institute of Technology recently launched a center for the printing of cells, tissues and organs, where 3D scaffolds and cells that grow into tissue are constructed to aid treatment in all areas of regenerative medicine.
Three-dimensional printing of tissue helps researchers develop complex and precise artificial tissues that improve their integration in target organs. This involves the creation of tissue containing a developed system of blood vessels that quickly connect to patients’ own blood vessels. Continue Reading »
The India-Israel Industrial R&D and Technological Innovation Fund allocates $4.9M to finance a project to develop AI-based screening to identify major diseases early on, such as tuberculosis.
By Associated Press and Israel Hayom Staff
A major Indian hospital group and Israel’s Zebra Medical Vision have announced a new collaboration on a medical imaging initiative in India.
The project, which will focus on deploying AI (artificial intelligence)-based tools across India, is receiving $4.9 million in support from the India-Israel Industrial R&D and Technological Innovation Fund (I4F).
Israel’s Zebra Medical Vision is partnering with one of India’s largest hospital groups to deploy AI-based screening tools – Photo: Courtesy
The project is envisioned to serve as a primary large-scale screening method for major diseases. Continue Reading »
U.S. biopharmaceutical firm announced its decision to pay $11.9 billion for Kite Pharma, an Israeli biomed developing T-cell therapy that harnesses the body’s immune cells to attack malignant cells.
• This pharmaceutical acquisition is among the most spent for a company whose products have yet to be FDA approved.
By Zeev Klein, News Agencies & Israel Hayom Staff
Biopharmaceutical giant Gilead Sciences announced Monday that it has agreed to buy Israeli biomed company Kite Pharma for $11.9 billion in an all-cash deal. This acquisition marks one of the biggest ever deals for a company whose products have yet to be approved for marketing. Continue Reading »
CollPlant’s bio-ink enables the 3-D printing of tissue and organs, with the aim of providing a solution to the significant need of life saving organs.
By SHARON UDASIN
The Israeli regenerative medicine company CollPlant has filed a US to be used in the three-dimensional printing of tissues and organs.
CollPlant’s patent application refers to formulations of bio-ink based on the firm’s rhCollagen (recombinant type 1 human collage), a plant-based technology that mimics human collagen – the main structural protein in connective tissues. By filing the patent, the Ness Ziona-based company expressed hopes of establishing its position as a leader in three-dimensional biological printing and of forming partnerships in the field of organ printing. Continue Reading »
Kfar Saba-based cardiac monitoring clothing HealthWatch, raises $20 million from Chinese company Yiling, who will also market HealthWatch’s product in China.
By Israel Hayom Staff
Israeli startup HealthWatch Technologies, which develops cardiac monitoring garments, announced Monday a $20 million investment by Chinese company Yiling, which specializes in Chinese medicine and is now in the process of branching out into conventional medicine.
According to the financial daily Globes, the investment puts HealthWatch’s value at $65 million.
HealthWatch describes itself as “a pioneer in harnessing textile technology to produce fashionable, smart-digital garments with interwoven sensors unobtrusively measuring vital signs of hospital-grade quality.” Continue Reading »
Researcher led by Tel Aviv University’s Dr. Carmit Levy have discovered the method by which cancer cells inflict themselves on the dermis, now allowing scientists to develop new drugs to cure the disease.
By JUDY SIEGEL-ITZKOsVICH
The mechanism by which melanoma – the most aggressive and deadly type of skin cancer – spreads through the body has been discovered by Tel Aviv University and German Cancer Research (DKFZ) researchers.
Medical student conducting research – Photo: TAU’s Sackler School of Medicine
The “breakthrough,” just published as the lead article in the journal Nature Cell Biology has raised hope that it will lead to the cancer becoming “nonthreatening and easily curable.” Continue Reading »
Israeli professor from the Technion said, “Precisely because I am not a doctor, I was able to conceive such a unique development – an inexpensive & noninvasive system for diagnosing diseases based on breath.”
Prof. Hossam Haick of Haifa’s Technion-Israel Institute of Technology received the Humboldt Research Award in Germany and was also chosen as one of the 100 influential figures published by California’s Good Magazine over the weekend. He has been prominent, among other things in his development of devices to diagnose and monitor various types of cancers (lung, breast, colon, gastric, head and neck, ovarian, kidney and bladder malignancies) via breath samples. Continue Reading »
Researchers from Tel Aviv University say the smart tissue will be aware of the heart beat and intervene when it’s not functioning properly, providing regular reports to the patient & cardiologist.
Ilan Gattegno and Israel Hayom Staff
In a significant breakthrough, researchers from Tel Aviv University say they have engineered a bionic heart.
A computerized image of the bionic heart engineered by researchers at Tel Aviv University
The heart, comprised of smart tissue transplanted into patients, will be able to monitor and regulate tissue function. The smart tissue will help the heart beat and intervene when it’s not functioning properly, and provide an exact and regular report to the patient and cardiologist. Continue Reading »
Seeking to treat the root of several aging-related diseases, the new clinical trial is testing whether medication can delay onset of certain illnesses, such as cancer, heart disease, and cognitive impairment.
By Liat Levy
The cultural fixation with youth has permeated industries from cosmetics, pharmaceuticals, food, supplements and more. We are frequently hearing that a magical cure is just around the corner.
Dr. Nir Barzilai
Professor Nir Barzilai, director and founder of the Institute for Aging Research at Yeshiva University’s Albert Einstein College of Medicine, has more reason than most to believe that this is not far from the truth. Continue Reading »
In coordination with the Soroka Medical Center, the Health Ministry’s Emergency Dept, the IDF Home Front Command, & the IDF Medical Corps, hundreds of int’l health professionals visit Israeli hospitals to learn how to effectively deal with a natural disaster or massive terror attack.
By Michael Bachner, TPS
Hundreds of professionals from 30 countries participated in a large-scale exercise at the Soroka Medical Center in Be’er Sheva this week, simulating the evacuation of dozens of casualties following a massive terrorist attack.
International exercise in Soroka on dealing with disasters – Photo: Shmaryahu Spero, TPS
Dozens of simulated casualties with various degrees of injury were evacuated to Soroka in scenarios mimicking a terror attack in a populated urban facility and leakage of hazardous materials from a train car. Continue Reading »
Israeli start-up launches mini molecular sensor that tells you how many calories are in your burger, how ripe a tomato is, if a leather jacket is real, and much more.
An Israeli start-up has launched a pocket device which analyzes instantly the composition of food, drink, medication or other objects.
A staff of the Laboratory of the Consumer Physics Society performs a test on a chocolate bar using SCIO – Photo: AFP
It is “the first molecular sensor that fits in the palm of your hand,” says Dror Sharon, co-founder of the firm based in Hod Hasharon, near Tel Aviv. Continue Reading »
In one of Israel’s most successful exits for a biomedical start-up, HeartWare Int’l, a U.S.-based medical device developer, acquires Valtech Cardio, a developer of heart valve repair & replacement technology.
By Hezi Sternlicht, Israel Hayom Staff & News Agencies
Israeli medical startup Valtech Cardio announced Wednesday that it had been acquired by global medical device developer HeartWare International. The deal is estimated at $920 million, making it one of the most successful exits for an Israeli biomedical company.
Valtech Cardio develops innovative surgical instruments – Screenshot: Valtech
Continue Reading »
Based in Or Yehuda, in central Israel, Valtech was founded in 2006 by Amir and Yossi Gross, and has 50 employees.